查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2040388

美容注射劑市場規模、佔有率和趨勢分析報告：按產品、應用、最終用途、地區和細分市場預測（2026-2033 年）

Aesthetic Injectable Market Size, Share & Trends Analysis Report By Product, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 225 Pages | 商品交期: 2-10個工作天內

價格

注射美容產品市場概覽

2025年全球美容注射劑市場規模估計為1,11億美元，預計2033年將達到241億美元。

預計從 2026 年到 2033 年，該行業將以 10.0% 的複合年成長率成長。對微創美容手術日益成長的需求是推動美容注射藥物行業成長的主要動力。

消費者越來越傾向於選擇恢復期短、效果自然的非手術美容療法，這推動了肉毒桿菌、皮膚填充劑和生物促效劑注射等產品的流行。這些治療方法能夠有效解決皺紋、容量流失和膚質等問題，帶來即時到漸進的自然效果。這種轉變擴大了消費者群體，既包括尋求改善症狀的人群，也包括尋求預防性照護的人群。 2024年6月發表在《歐洲整形外科雜誌》上的一篇論文分析了德國、奧地利和瑞士的511個網站，強調了非手術美容療法的強勁市場需求，並支持其在現代臨床實踐中日益重要的作用。

注射療法的社會接受度不斷提高，使其客戶群超越了傳統人群。年輕消費者將皮膚填充劑視為積極老齡化的一種方式，而年長消費者則欣賞無需手術即可重獲青春容顏的能力。隨著這些療法透過意見領袖和專家的推廣而日益普及，無論是在都市區市場還是新興市場，需求都持續成長。病人重視能夠以循序漸進且經濟實惠的方式，根據自身喜好客製化治療方案。由經驗豐富的專業人士指導的、規劃完善的美容護理方案的廣泛應用，進一步增強了人們對這些療法的信心。 2024年1月，艾爾建美學宣布，其會員忠誠度獎勵計畫Alle在一項消費者調查中獲得了92%的滿意度。 Alle擁有超過600萬會員，提供包括費用優惠、非Alle專案積分以及為常客提供的專屬福利等，使其成為消費者和醫療保健提供者信賴的平台。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：注射美容市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 用於分析美容注射市場的工具。

第4章：注射美容市場：產品細分市場估算及趨勢分析

  • 美容注射市場：產品特定流體波動分析
  • 美容注射劑市場：產品展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 膠原蛋白和PMMA微球
  • 玻尿酸
    • 單相
    • 雙相
  • 羥磷石灰鈣（CaHA）
  • PLLA
  • PCL
  • PN/PDRN
  • 肉毒桿菌素（Botox）

第5章：注射美容市場：按應用分類的估算和趨勢分析

  • 注射美容市場：按應用領域分類的波動分析
  • 美容注射劑市場：按應用領域分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 改善皺紋
  • 唇部豐盈度增加
  • 臉部輪廓
  • 疤痕治療
  • 容量損失修復
  • 其他

第6章：注射美容市場：依最終用途分類的估算與趨勢分析

  • 美容注射劑市場：按最終用途分類的波動分析
  • 美容注射劑市場：按最終用途分類的展望
  • 市場規模、預測與趨勢分析，2021-2033年
  • 醫療水療中心
  • 醫院
  • 整形外科中心
  • 其他

第7章：注射美容市場：區域估算與趨勢分析

  • 區域儀錶板
  • 美容注射劑區域市場波動分析
  • 注射美容市場：區域預測與趨勢分析
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
    • 俄羅斯
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
    • 新加坡
    • 馬來西亞
    • 台灣
    • 越南
    • 菲律賓
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭情勢

  • 參與企業的分類
  • 主要公司簡介
    • AbbVie Inc.
    • Galderma
    • Merz GmbH and Co. KGaA
    • Sinclair
    • Medytox
    • Prollenium Medical Technologies
    • Tiger Aesthetics Medical（Suneva Medical, Inc.）
    • HUGEL, Inc.
    • Ipsen Pharma
    • Teoxane
Product Code: GVR-4-68040-275-9

Aesthetic Injectable Market Summary

The global aesthetic injectable market size was estimated at USD 11.1 billion in 2025 and is projected to reach USD 24.1 billion by 2033, growing at a CAGR of 10.0% from 2026 to 2033. The rising demand for minimally invasive aesthetic procedures is significantly driving the growth of the aesthetic injectables industry.

Consumers are increasingly seeking subtle, non-surgical enhancements with minimal downtime, boosting the adoption of products such as botulinum toxins, dermal fillers, and biostimulatory injectables. These treatments effectively address concerns such as wrinkles, volume loss, and skin quality, delivering natural-looking results from immediate to gradual effects. This shift has expanded the consumer base to include both corrective and preventive users. In June 2024, an article published in the European Journal of Plastic Surgery analyzed 511 websites across Germany, Austria, and Switzerland, highlighting the strong presence and demand for non-surgical aesthetic procedures, reinforcing their growing role in modern clinical practice.

The social acceptance of injectable treatments has also expanded the customer base beyond traditional segments. Younger consumers view dermal fillers as a proactive approach to aging, while older individuals appreciate the restoration of youthful features without going under the knife. With influencers and professionals normalizing these treatments, demand continues to grow in both urban and emerging markets. Patients value the ability to personalize results progressively and affordably. The rise of curated aesthetic journeys, guided by skilled practitioners, reinforces confidence in these procedures. In January 2024, Allergan Aesthetics revealed that its Alle loyalty rewards program achieved a 92% satisfaction rate in a consumer survey. Serving over six million members, Alle offers benefits such as cost savings, points on non-Alle treatments, and exclusive rewards for loyal users, making it a trusted resource for consumers and providers alike.

Global Aesthetic Injectable Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. Forthis study, Grand View Research has segmented the global aesthetic injectable market report based on product, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Collagen and PMMA Microspheres
  • Hyaluronic Acid
    • Monophasic
    • Biphasic
  • Calcium Hydroxylapatite (CaHA)
  • PLLA
  • PCL
  • PN/PDRN
  • Botulinum Toxin (Botox)
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Wrinkle Correction
  • Lip Augmentation
  • Facial Contouring
  • Scar Treatment
  • Volume Loss Restoration
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • MedSpas
  • Aesthetic Surgery Centers
  • Hospitals
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
    • Russia
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
    • Australia
    • Singapore
    • Malaysia
    • Taiwan
    • India
    • Vietnam
    • Philippines
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Aesthetic Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Aesthetic Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Aesthetic Injectable Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Aesthetic Injectable Market: Product Movement Analysis
  • 4.3. Aesthetic Injectable Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Collagen and PMMA Microspheres
    • 4.5.1. Collagen and PMMA Microspheres Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Hyaluronic Acid
    • 4.6.1. Hyaluronic Acid Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Monophasic
      • 4.6.2.1. Monophasic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Biphasic
      • 4.6.3.1. Biphasic Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Calcium Hydroxylapatite (CaHA)
    • 4.7.1. Calcium Hydroxylapatite (CaHA) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. PLLA
    • 4.8.1. PLLA Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.9. PCL
    • 4.9.1. PCL Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.10. PN/PDRN
    • 4.10.1. PN/PDRN Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.11. Botulinum Toxin (Botox)
    • 4.11.1. Botulinum Toxin (Botox) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Aesthetic Injectable Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Aesthetic Injectable Market: Application Movement Analysis
  • 5.3. Aesthetic Injectable Market by Application Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Wrinkle Correction
    • 5.5.1. Wrinkle Correction Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Lip Augmentation
    • 5.6.1. Lip Augmentation Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Facial Contouring
    • 5.7.1. Facial Contouring Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Scar Treatment
    • 5.8.1. Scar Treatment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Volume Loss Restoration
    • 5.9.1. Volume Loss Restoration Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Aesthetic Injectable Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Aesthetic Injectable Market: End Use Movement Analysis
  • 6.3. Aesthetic Injectable Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. MedSpas
    • 6.5.1. MedSpas Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Hospitals
    • 6.6.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Aesthetic Surgery Centers
    • 6.7.1. Aesthetic Surgery Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Aesthetic Injectable Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Aesthetic Injectable Market Movement Analysis
  • 7.3. Aesthetic Injectable Market: Regional Estimates & Trend Analysis by Product & Source
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. North America
    • 7.5.1. North America Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. UK Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Germany Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. France Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Italy Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Spain Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.7. Denmark
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Denmark Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Sweden Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.9. Norway
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Competitive Scenario
      • 7.6.9.3. Regulatory Framework
      • 7.6.9.4. Reimbursement scenario
      • 7.6.9.5. Norway Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.10. Russia
      • 7.6.10.1. Key Country Dynamics
      • 7.6.10.2. Competitive Scenario
      • 7.6.10.3. Regulatory Framework
      • 7.6.10.4. Reimbursement scenario
      • 7.6.10.5. Russia Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Japan Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. China Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. India Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Australia Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Thailand Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.8. Singapore
      • 7.7.8.1. Key Country Dynamics
      • 7.7.8.2. Competitive Scenario
      • 7.7.8.3. Regulatory Framework
      • 7.7.8.4. Reimbursement scenario
      • 7.7.8.5. Singapore Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.9. Malaysia
      • 7.7.9.1. Key Country Dynamics
      • 7.7.9.2. Competitive Scenario
      • 7.7.9.3. Regulatory Framework
      • 7.7.9.4. Reimbursement scenario
      • 7.7.9.5. Malaysia Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.10. Taiwan
      • 7.7.10.1. Key Country Dynamics
      • 7.7.10.2. Competitive Scenario
      • 7.7.10.3. Regulatory Framework
      • 7.7.10.4. Reimbursement scenario
      • 7.7.10.5. Taiwan Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.11. Vietnam
      • 7.7.11.1. Key Country Dynamics
      • 7.7.11.2. Competitive Scenario
      • 7.7.11.3. Regulatory Framework
      • 7.7.11.4. Reimbursement scenario
      • 7.7.11.5. Vietnam Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.12. Philippines
      • 7.7.12.1. Key Country Dynamics
      • 7.7.12.2. Competitive Scenario
      • 7.7.12.3. Regulatory Framework
      • 7.7.12.4. Reimbursement scenario
      • 7.7.12.5. Philippines Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Brazil Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. South Africa Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Saudi Arabia Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. UAE Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Competitive Scenario
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement scenario
      • 7.9.5.5. Kuwait Aesthetic Injectable Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. AbbVie Inc.
      • 8.2.1.1. Company Overview
      • 8.2.1.2. Financial Performance
      • 8.2.1.3. Product Benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. Galderma
      • 8.2.2.1. Company Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. Merz GmbH and Co. KGaA
      • 8.2.3.1. Company Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Sinclair
      • 8.2.4.1. Company Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Medytox
      • 8.2.5.1. Company Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Prollenium Medical Technologies
      • 8.2.6.1. Company Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. Tiger Aesthetics Medical (Suneva Medical, Inc.)
      • 8.2.7.1. Company Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. HUGEL, Inc.
      • 8.2.8.1. Company Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. Ipsen Pharma
      • 8.2.9.1. Company Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Teoxane
      • 8.2.10.1. Company Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 Global Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 5 Global Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 6 North America Aesthetic Injectable Market, by Country, 2021 - 2033 (USD Million)
  • Table 7 North America Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 8 North America Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 9 North America Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 10 U.S. Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 11 U.S. Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 12 U.S. Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 13 Canada Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 14 Canada Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 15 Canada Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Mexico Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 17 Mexico Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 18 Mexico Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 19 Europe Aesthetic Injectable Market, by Country, 2021 - 2033 (USD Million)
  • Table 20 Europe Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 21 Europe Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 22 Europe Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 Germany Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 24 Germany Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 25 Germany Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 26 Spain Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 27 Spain Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 28 Spain Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 UK Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 30 UK Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 31 UK Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 32 Italy Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 33 Italy Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 34 Italy Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 France Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 36 France Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 37 France Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 38 Denmark Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 39 Denmark Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 40 Denmark Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41 Sweden Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 42 Sweden Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 43 Sweden Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 44 Norway Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 45 Norway Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 46 Norway Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 47 Russia Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 48 Russia Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 49 Russia Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific Aesthetic Injectable Market, by Country, 2021 - 2033 (USD Million)
  • Table 51 Asia Pacific Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 52 Asia Pacific Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 53 Asia Pacific Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 India Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 India Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 56 India Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 57 Japan Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 58 Japan Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 59 Japan Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 60 China Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 61 China Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 62 China Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 Australia Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 64 Australia Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 65 Australia Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 South Korea Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 67 South Korea Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 68 South Korea Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 69 Thailand Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 70 Thailand Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 71 Thailand Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 72 Singapore Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 73 Singapore Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 74 Singapore Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 75 Malaysia Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 76 Malaysia Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 77 Malaysia Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 78 Taiwan Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 79 Taiwan Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 80 Taiwan Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 81 Vietnam Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 82 Vietnam Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 83 Vietnam Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 84 Philippines Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 85 Philippines Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 86 Philippines Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 87 Latin America Aesthetic Injectable Market, by Country, 2021 - 2033 (USD Million)
  • Table 88 Latin America Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 89 Latin America Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 90 Latin America Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 91 Argentina Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 92 Argentina Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 93 Argentina Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 94 Brazil Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 95 Brazil Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 96 Brazil Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 97 Middle East & Africa Aesthetic Injectable Market, by Country, 2021 - 2033 (USD Million)
  • Table 98 Middle East & Africa Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 99 Middle East & Africa Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 100 Middle East & Africa America Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 101 Saudi Arabia Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 102 Saudi Arabia Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 103 Saudi Arabia Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 104 South Africa Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 105 South Africa Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 106 South Africa Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 107 UAE Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 108 UAE Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 109 UAE Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)
  • Table 110 Kuwait Aesthetic Injectable Market, by Product, 2021 - 2033 (USD Million)
  • Table 111 Kuwait Aesthetic Injectable Market, by Application, 2021 - 2033 (USD Million)
  • Table 112 Kuwait Aesthetic Injectable Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Value chain-based sizing & forecasting
  • Fig. 5 Market formulation & validation
  • Fig. 6 Aesthetic injectable market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Aesthetic injectable market, product outlook key takeaways (USD Million)
  • Fig. 12 Aesthetic injectable market: product movement analysis 2025 & 2033 (USD Million)
  • Fig. 13 Collagen and PMMA microspheres market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Hyaluronic acid market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Monophasic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Biphasic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Calcium hydroxylapatite (CaHA) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 PLLA market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 PCL market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 PN/PDRN market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Botulinum toxin (Botox) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Aesthetic injectable market, application outlook key takeaways (USD Million)
  • Fig. 23 Aesthetic injectable market: application movement analysis 2025 & 2033 (USD Million)
  • Fig. 24 Wrinkle correction market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Lip augmentation market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Facial contouring market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Scar treatment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Volume loss restoration market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Aesthetic injectable market, end use outlook key takeaways (USD Million)
  • Fig. 31 Aesthetic injectable market: end use movement analysis 2025 & 2033 (USD Million)
  • Fig. 32 MedSpas market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Aesthetic surgery centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Aesthetic injectable market, regional key takeaways (USD Million)
  • Fig. 37 Aesthetic injectable market regional outlook, 2025 & 2033 (USD Million)
  • Fig. 38 North America aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 U.S. aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Canada aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Mexico aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Europe aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 UK aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Germany aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 France aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Italy aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Spain aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Denmark aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Norway aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Russia aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Asia Pacific aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Japan aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 China aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 India aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Australia aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 South Korea aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Thailand aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Singapore aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Malaysia aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Taiwan aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Vietnam aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Philippines aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Brazil aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Argentina aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Middle East & Africa aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 South Africa aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Saudi Arabia aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 UAE aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Kuwait aesthetic injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 List of key emerging companies/indication disruptors/innovators